Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

Renal Denervation: Poised for a Comeback?

The renal denervation market flamed out in 2014, after four years of breakneck activity. But a resurrection of sorts is now underway, led by Medtronic and ReCor Medical. We explore the prospects for a near-term renal denervation revival and what that would mean for the medtech industry and the global hypertension community.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Perspective & Commentary

Pediatric Device Showcase: Novonate’s LifeBubble

Novonate is a commercial-stage company dedicated to designing products that solve problems in neonatal care. The company is currently commercializing its first product, the LifeBubble, a novel device for the securement of umbilical cord catheters. Health Advances interviewed the co-founder and CEO of Novonate, Eric Chehab, PhD, to discuss the company’s progress to date and advice for pediatric device entrepreneurs. By Andrew Millar, Shoumyo Majumdar, PhD, and Susan Posner.

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
More From MedTech Strategist:

Santé Ventures: Investing in the Time of COVID

COVID-19’s impact on the medical device industry will be measured in its corresponding effect on medtechs' customers: hospitals and health systems. Given their deep background in the provider community, the principals at Santé Ventures offer a glimpse into the pandemic’s impact.

Read Article